Local adjuvant treatment of clinical stage I-II melanoma with low dose CpG-B and/or GM-CSF: Long-term follow-up of three randomized controlled phase II trials

This article has no abstract
Epistemonikos ID: 580d6ee94c1f25768c54bc12eccdc40c6cfb4d50
First added on: Feb 08, 2025